General Information of the Compound
| Compound ID |
CP0447097
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propyl]imidazo[1,2-a]pyridine-3-sulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H24FN5O3S
|
||||||||||||||||||
| Molecular Weight |
457.531
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc2c(noc2c1)C1CCN(CCCNS(=O)(=O)c2cnc3ccccn23)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H24FN5O3S/c23-17-5-6-18-19(14-17)31-26-22(18)16-7-12-27(13-8-16)10-3-9-25-32(29,30)21-15-24-20-4-1-2-11-28(20)21/h1-2,4-6,11,14-16,25H,3,7-10,12-13H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
OOTYIPXZQVEHNY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor